Surgical Management of Bone Metastases

  • Markku Nousiainen
  • Cari Whyne
  • Albert Yee
  • Joel Finkelstein
  • Michael Ford
Part of the Cancer Metastasis – Biology and Treatment book series (CMBT, volume 12)


Orthopaedic and spinal surgery can provide significant palliation to patients with symptoms arising for bony metastatic involvement in addition to patients that are at risk for skeletally related events (SREs). This chapter will review the role of surgery in the management of bone metastases and discuss factors that need to be considered prior to surgery. The treatment of pathologic fractures and the evaluation of pre-critical bony lesions will be presented. An overview of assessing the need for potential surgical intervention(s) by different criteria and reported scoring systems will be reviewed as well as a synopsis of the surgical treatment and management for appendicular, pelvic, and vertebral metastasis. Novel approaches to more accurately guide fracture risk prediction radiologically will be presented and the role of emergent surgery discussed.


Bone metastases Surgery Skeletal related events Fracture 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Janjan N (2001) Bone metastases: approaches to management. Semin Oncol 28: 28–34PubMedCrossRefGoogle Scholar
  2. 2.
    Swanson KC, Pritchard DJ, Sim FH (2000) Surgical treatment of metastatic disease of the femur. J Am Acad Orthop Surg 8: 56–65PubMedGoogle Scholar
  3. 3.
    Hage WD, Aboulafia AJ, Aboulafia DM (2000) Incidence, location, and diagnostic evaluation of metastatic bone disease. Orthop Clin North Am 31: 515–528, viiPubMedCrossRefGoogle Scholar
  4. 4.
    Bauer HC (2005) Controversies in the surgical management of skeletal metastases. J Bone Joint Surg Br 87: 608–617PubMedCrossRefGoogle Scholar
  5. 5.
    Sim FH (1992) Metastatic bone disease of the pelvis and femur. Instr Course Lect 41: 317–327PubMedGoogle Scholar
  6. 6.
    Healey JH, Brown HK (2000) Complications of bone metastases: surgical management. Cancer 88: 2940–2951PubMedCrossRefGoogle Scholar
  7. 7.
    Galasko CS (1972) Skeletal metastases and mammary cancer. Ann R Coll Surg Engl 50: 3–28PubMedGoogle Scholar
  8. 8.
    Bauer HC, Wedin R (1995) Survival after surgery for spinal and extremity metastases. Prognostication in 241 patients. Acta Orthop Scand 66: 143–146Google Scholar
  9. 9.
    Hansen BH, Keller J, Laitinen M, et al. (2004) The Scandinavian Sarcoma Group skeletal metastasis register. Survival after surgery for bone metastases in the pelvis and extremities. Acta Orthop Scand Suppl 75: 11–15Google Scholar
  10. 10.
    Katagiri H, Takahashi M, Wakai K, et al. (2005) Prognostic factors and a scoring system for patients with skeletal metastasis. J Bone Joint Surg Br 87: 698–703PubMedCrossRefGoogle Scholar
  11. 11.
    Harrington KD (1997) Orthopedic surgical management of skeletal complications of malignancy. Cancer 80: 1614–1627PubMedCrossRefGoogle Scholar
  12. 12.
    Harrington KD (1986) Impending pathologic fractures from metastatic malignancy: evaluation and management. Instr Course Lect 35: 357–381PubMedGoogle Scholar
  13. 13.
    Finkelstein JA, Zaveri G, Wai E, et al. (2003) A population-based study of surgery for spinal metastases. Survival rates and complications. J Bone Joint Surg Br 85: 1045–1050CrossRefGoogle Scholar
  14. 14.
    Fidler M (1981) Incidence of fracture through metastases in long bones. Acta Orthop Scand 52: 623–627PubMedCrossRefGoogle Scholar
  15. 15.
    Menck H, Schulze S, Larsen E (1988) Metastasis size in pathologic femoral fractures. Acta Orthop Scand, 1988. 59: 151–154Google Scholar
  16. 16.
    Mirels H (1989) Metastatic disease in long bones: a proposed scoring system for diagnosing impending pathologic fractures. Clin Orthop Relat Res 249: 256–264PubMedGoogle Scholar
  17. 17.
    Mirels H (1989) Metastatic disease in long bones: a proposed scoring system for diagnosing impending pathologic fractures. Clin Orthop Relat Res 415: S4–S13CrossRefGoogle Scholar
  18. 18.
    Damron TA, Morgan H, Prakash D, et al. (2003) Critical evaluation of Mirels’ rating system for impending pathologic fractures. Clin Orthop Relat Res 415: S201–S207PubMedCrossRefGoogle Scholar
  19. 19.
    Patchell RA, Tibbs PA, Regine WF, et al. (2005) Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 366: 643–648PubMedCrossRefGoogle Scholar
  20. 20.
    Tokuhashi Y, Matsuzaki H, Toriyama S, et al. (1990) Scoring system for the preoperative evaluation of metastatic spine tumor prognosis. Spine 15: 1110–1113PubMedCrossRefGoogle Scholar
  21. 21.
    Tokuhashi Y, Matsuzaki H, Oda H, et al. (2005) A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine 30: 2186–2191PubMedCrossRefGoogle Scholar
  22. 22.
    Enkaoua EA, Doursonnian L, Chatellier G, et al. (1997) Vertebral metastases: a critical appreciation of the preoperative prognostic Tokuhashi score in a series of 71 cases. Spine 22: 2293–2298PubMedCrossRefGoogle Scholar
  23. 23.
    Huch K, Cakir B, Ulmar B, et al. (2005) Prognosis, surgical therapy and progression in cervical and upper-thoracic tumor osteolysis. Z Orthop Ihre Grenzgeb 143: 213–218PubMedCrossRefGoogle Scholar
  24. 24.
    Ulmar B, Huch K, Naumann U, et al. (2007) Evaluation of the Tokuhashi prognosis score and its modifications in 217 patients with vertebral metastases. Eur J Surg Oncol 33: 914–919PubMedGoogle Scholar
  25. 25.
    Ulmar B (2007) Prognosis scores of Tokuhashi and Tomita for patients with spinal metastases of renal cancer. Ann Surg Oncol 14: 998–1004PubMedCrossRefGoogle Scholar
  26. 26.
    Ulmar B, Richter M, Cakir B, et al. (2005) The Tokuhashi score: significant predictive value for the life expectancy of patients with breast cancer with spinal metastases. Spine 30: 2222–2226PubMedCrossRefGoogle Scholar
  27. 27.
    Taneichi H, Kaneda K, Takeda N, et al. (1997) Risk factors and probability of vertebral body collapse in metastases of the thoracic and lumbar spine. Spine 22: 239–245PubMedCrossRefGoogle Scholar
  28. 28.
    Hipp JA, Springfield DS, Hayes WC (1995) Predicting pathologic fracture risk in the management of metastatic bone defects. Clin Orthop Relat Res 312: 120–135PubMedGoogle Scholar
  29. 29.
    Keene JS, Sellinger DS, McBeath AA, et al. (1986) Metastatic breast cancer in the femur. a search for the lesion at risk of fracture. Clin Orthop Relat Res 203: 282–288Google Scholar
  30. 30.
    Hipp JA, Katz G, Hayes WC (1991) Local demineralization as a model for bone strength reductions in lytic transcortical metastatic lesions. Invest Radiol 26: 934–938PubMedCrossRefGoogle Scholar
  31. 31.
    Haller J, Andre MP, Resnick D, et al. (1990) Detection of thoracolumbar vertebral body destruction with lateral spine radiography. Part II: clinical investigation with computed tomography. Invest Radiol 25: 523–532Google Scholar
  32. 32.
    Constans JP, de Divitiis E, Donzelli R, et al. (1983) Spinal metastases with neurological manifestations. Review of 600 cases. J Neurosurg 59: 111–118Google Scholar
  33. 33.
    Whealan KM, Kwak SD, Tedrow JR, et al. (2000) Noninvasive imaging predicts failure load of the spine with simulated osteolytic defects. J Bone Joint Surg Am 82: 1240–1251PubMedGoogle Scholar
  34. 34.
    Hong J, Cabe GD, Tedrow JR, et al. (2004) Failure of trabecular bone with simulated lytic defects can be predicted non-invasively by structural analysis. J Orthop Res 22: 479–486PubMedCrossRefGoogle Scholar
  35. 35.
    Snyder BD, Hanser-Kara DA, Hipp JA, et al. (2006) Predicting fracture through benign skeletal lesions with quantitative computed tomography. J Bone Joint Surg Am 88: 55–70Google Scholar
  36. 36.
    Windhagen HJ, Hipp JA, Silva MJ, et al. (1997) Predicting failure of thoracic vertebrae with simulated and actual metastatic defects. Clin Orthop Relat Res 344: 313–319PubMedCrossRefGoogle Scholar
  37. 37.
    Windhagen H, Hipp JA, Hayes WC (2000) Postfracture instability of vertebrae with simulated defects can be predicted from computed tomography data. Spine 25: 1775–1781PubMedCrossRefGoogle Scholar
  38. 38.
    Whyne CM, Hu SS, Lotz JC (2003) Biomechanically derived guideline equations for burst fracture risk prediction in the metastatically involved spine. J Spinal Disord Tech 16: 180–185PubMedGoogle Scholar
  39. 39.
    Roth SE, Mousavi P, Finkelstein J, et al. (2004) Metastatic burst fracture risk prediction using biomechanically based equations. Clin Orthop Relat Res 419: 83–90PubMedCrossRefGoogle Scholar
  40. 40.
    Hardisty M, Gordon L, Aqarwal P, et al. (2007) Quantitative characterization of metastatic disease in the spine. Part I. Semiautomated segmentation using atlas-based deformable registration and the level set method. Med Phys 34: 3127–3134Google Scholar
  41. 41.
    Whyne C, Hardisty M, Wu F, et al. (2007) Quantitative characterization of metastatic disease in the spine. Part II. Histogram-based analyses. Med Phys 34: 3279–3285Google Scholar
  42. 42.
    Althausen P, Althausen A, Jennings LC, et al. (1997) Prognostic factors and surgical treatment of osseous metastases secondary to renal cell carcinoma. Cancer 80: 1103–1109PubMedCrossRefGoogle Scholar
  43. 43.
    Katzer A, Meenen NM, Grabbe F, et al. (2002) Surgery of skeletal metastases. Arch Orthop Trauma Surg 122: 251–258PubMedCrossRefGoogle Scholar
  44. 44.
    Jacofsky DJ, Haidukewych GJ (2004) Management of pathologic fractures of the proximal femur: state of the art. J Orthop Trauma 18: 459–469PubMedCrossRefGoogle Scholar
  45. 45.
    Papagelopoulos PJ, Savvidou OD, Galanis EC, et al. (2006) Advances and challenges in diagnosis and management of skeletal metastases. Orthopedics 29:609–620; quiz 621–622Google Scholar
  46. 46.
    Wunder JS, Ferguson PC, Griffin AM, et al. (2003) Acetabular metastases: planning for reconstruction and review of results. Clin Orthop Relat Res 415: S187–197PubMedCrossRefGoogle Scholar
  47. 47.
    Weber KL, Gebhardt MC (2003) What’s new in musculoskeletal oncology. J Bone Joint Surg Am 85-A: 761–767Google Scholar
  48. 48.
    Marco RA, Sheth DS, Boland PJ, et al. (2000) Functional and oncological outcome of \nobreak acetabular reconstruction for the treatment of metastatic disease. J Bone Joint Surg Am 82: 642–651PubMedGoogle Scholar
  49. 49.
    Aboulafia AJ, Buch R, Mathews J, et al. (1995) Reconstruction using the saddle prosthesis following excision of primary and metastatic periacetabular tumors. Clin Orthop Relat Res 314: 203–213PubMedGoogle Scholar
  50. 50.
    Allan DG, Bell RS, Davis A, et al. (1995) Complex acetabular reconstruction for metastatic tumor. J Arthroplasty 10: 301–306PubMedCrossRefGoogle Scholar
  51. 51.
    Stark A, Bauer HC (1996) Reconstruction in metastatic destruction of the acetabulum. Support rings and arthroplasty in 12 patients. Acta Orthop Scand 67: 435–438Google Scholar
  52. 52.
    Levy RN, Sherry HS, Siffert RS (1982) Surgical management of metastatic disease of bone at the hip. Clin Orthop Relat Res 169: 62–69PubMedGoogle Scholar
  53. 53.
    Harrington KD (1981) The management of acetabular insufficiency secondary to metastatic malignant disease. J Bone Joint Surg Am 63: 653–664PubMedGoogle Scholar
  54. 54.
    Abudu A, Grimer RJ, Cannon SR, et al. (1997) Reconstruction of the hemipelvis after the excision of malignant tumours. Complications and functional outcome of prostheses. J Bone Joint Surg Br 79: 773–779CrossRefGoogle Scholar
  55. 55.
    Renard AJ, Veth RP, Schreuder HW, et al. (2000) The saddle prosthesis in pelvic primary and secondary musculoskeletal tumors: functional results at several postoperative intervals. Arch Orthop Trauma Surg 120: 188–194PubMedCrossRefGoogle Scholar
  56. 56.
    Nilsson J, Gustafson P, Fornander P, et al. (2000) The Harrington reconstruction for advanced periacetabular metastatic destruction: good outcome in 32 patients. Acta Orthop Scand 71: 591–596PubMedCrossRefGoogle Scholar
  57. 57.
    Schreuder HW, Keijser LC, Veth RP (1999) Beneficial effects of cryosurgical treatment in benign and low-grade-malignant bone tumors in 120 patients. Ned Tijdschr Geneeskd 143: 2275–2281PubMedGoogle Scholar
  58. 58.
    Cotten A, Deprez X, Migaud H, et al. (1995) Malignant acetabular osteolyses: percutaneous injection of acrylic bone cement. Radiology 197: 307–310PubMedGoogle Scholar
  59. 59.
    Wai EK, Finkelstein JA, Tangente RP, et al. (2003) Quality of life in surgical treatment of metastatic spine disease. Spine 28: 508–512PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2009

Authors and Affiliations

  • Markku Nousiainen
    • 1
  • Cari Whyne
    • 1
  • Albert Yee
    • 1
  • Joel Finkelstein
    • 1
  • Michael Ford
    • 1
  1. 1.Department of SurgeryUniversity of Toronto, Orthopaedic Surgeon, Holland Ortopaedic and Arthritic Centre, Sunnybrook Health Sciences CentreTorontoCanada M4Y 1H1

Personalised recommendations